(Q41485776)

1 October 2017

title

Effects of guanidino and uremic compounds on nitric oxide pathways (English)

1 reference

1 October 2017

R J MacAllister

1

1 reference

1 October 2017

G S Whitley

series ordinal

2

1 reference

1 October 2017

P Vallance

series ordinal

3

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 March 1994

1 reference

1 October 2017

1 reference

1 October 2017

volume

45

1 reference

1 October 2017

issue

3

1 reference

1 October 2017

page(s)

737-742

1 reference

Role of endothelium-derived nitric oxide in the regulation of blood pressure

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.98

7 January 2021

Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.98

7 January 2021

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.98

7 January 2021

Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.98

7 January 2021

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.98

7 January 2021

The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: L-glutamine inhibits the generation of L-arginine by cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.98

7 January 2021

Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.98

7 January 2021

Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.98

7 January 2021

Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.98

7 January 2021

Identification of guanidino succinate as a putative endogenous source of the endothelium derived relaxing factor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.98

7 January 2021

Arginine derivatives and uraemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.98

7 January 2021

Nitric oxide synthase inhibitor dose-dependently and reversibly reduces the threshold for halothane anesthesia. A role for nitric oxide in mediating consciousness?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.98

7 January 2021

Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.98

7 January 2021

Enhanced nitric oxide synthesis in uremia: Implications for platelet dysfunction and dialysis hypotension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.98

7 January 2021

Identifiers

DOI

10.1038/KI.1994.98

1 reference

Dimensions Publication ID

1 October 2017

1028449008

0 references

1 reference